Company / Working Capital per Share
Gilead Sciences Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.24
FY2025
5-year range
$2.52 / $5.75
FY2021-FY2025
Trend
-8.9%
vs FY2024
Sector context
#109 of 210
Health Care
What the data says
At $5.24, Gilead Sciences's working capital per share ranks #109 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.52 in FY2021 to $19.29 in FY2018.
Based on SEC 10-K filings.
5.24 in FY2025 with a 5-year CAGR of +7.6%.
Improved from $3.85 to $5.24 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +27.0%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
#109 of 210 in Health CareTop 52% of 210This company $5.24 Sector average $146.86
▼
-96.4% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 8.9% year-over-year.
- Ranks #109 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.24 | -8.9% |
| FY2024 | $5.75 | +49.3% |
| FY2023 | $3.85 | +50.7% |
| FY2022 | $2.56 | +1.4% |
| FY2021 | $2.52 | -30.6% |
| FY2020 | $3.63 | -77.3% |
| FY2019 | $16.02 | -17.0% |
| FY2018 | $19.29 | +25.2% |
| FY2017 | $15.41 | +95.2% |
| FY2016 | $7.89 | -20.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026